Geron | GERN - Операционный доход





Операционный доход Изменить Дата
Amgen USD 3.83B 130M 2026-03
Bio Techne USD 75.49M 21.03M 2026-03
Cassava Sciences USD -13.55M 1.69M 2025-12
Cytokinetics USD -181.23M 2.86M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Exelixis USD 251.34M 15.43M 2026-03
Genmab DKK 260M 199M 2025-12
Geron USD -236K 10.55M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Incyte USD 324.17M 59.7M 2026-03
MacroGenics USD -12.1M 30.74M 2025-12
Novartis USD 4.24B 171M 2026-03
Novavax USD 20.94M 100.32M 2025-12